Skip to main content
. Author manuscript; available in PMC: 2012 May 16.
Published in final edited form as: Aliment Pharmacol Ther. 2008 Jun 11;28(4):431–442. doi: 10.1111/j.1365-2036.2008.03765.x

Figure 2.

Figure 2

Comparison of the percentage of patients in the two treatment groups with multiple gastroduodenal erosions/ulcers (change in Lanza scores >2) using different age cut-offs. It can be appreciated that Ibuprofen consistently caused a greater percentage of subjects to sustain more severe gastroduodenal injury (Lanza score >2) than those treated with Ibuprofen-PC in subjects older than 45 years of age.